Bradley Foster & Sargent Inc. CT Increases Stake in Novanta Inc. $NOVT

Bradley Foster & Sargent Inc. CT increased its stake in Novanta Inc. (NASDAQ:NOVT) by 10.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,172 shares of the technology company’s stock after purchasing an additional 6,128 shares during the period. Bradley Foster & Sargent Inc. CT owned 0.19% of Novanta worth $6,727,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Envestnet Asset Management Inc. increased its position in shares of Novanta by 15.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 81,691 shares of the technology company’s stock valued at $8,181,000 after acquiring an additional 10,896 shares during the period. Bessemer Group Inc. lifted its position in Novanta by 24.8% during the 3rd quarter. Bessemer Group Inc. now owns 222,391 shares of the technology company’s stock worth $22,272,000 after acquiring an additional 44,252 shares during the period. Teacher Retirement System of Texas lifted its position in Novanta by 51.2% during the 2nd quarter. Teacher Retirement System of Texas now owns 9,666 shares of the technology company’s stock worth $1,246,000 after acquiring an additional 3,272 shares during the period. Exchange Traded Concepts LLC grew its stake in Novanta by 22.1% during the 3rd quarter. Exchange Traded Concepts LLC now owns 178,375 shares of the technology company’s stock valued at $17,864,000 after purchasing an additional 32,278 shares during the last quarter. Finally, Congress Asset Management Co. acquired a new position in shares of Novanta in the third quarter valued at about $59,153,000. Hedge funds and other institutional investors own 98.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Robert W. Baird set a $150.00 target price on Novanta in a report on Wednesday. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Finally, Weiss Ratings raised shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Novanta has a consensus rating of “Hold” and an average target price of $150.00.

Novanta Stock Down 3.1%

NOVT opened at $133.22 on Thursday. The company has a fifty day moving average of $132.74 and a two-hundred day moving average of $120.13. The stock has a market capitalization of $4.75 billion, a price-to-earnings ratio of 91.25 and a beta of 1.62. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $153.20. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.54 and a current ratio of 3.69.

Novanta (NASDAQ:NOVT) last posted its earnings results on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.88 by $0.03. The firm had revenue of $258.35 million for the quarter, compared to analysts’ expectations of $260.72 million. Novanta had a return on equity of 13.12% and a net margin of 5.49%.During the same period last year, the firm earned $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, research analysts expect that Novanta Inc. will post 3.03 earnings per share for the current year.

Insider Activity at Novanta

In other news, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $140.88, for a total transaction of $200,472.24. Following the completion of the transaction, the chief financial officer directly owned 93,814 shares of the company’s stock, valued at $13,216,516.32. This represents a 1.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the transaction, the chief executive officer owned 57,367 shares in the company, valued at $8,320,509.68. This trade represents a 11.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 24,346 shares of company stock valued at $3,382,737. Corporate insiders own 1.20% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.